Gain Contingency, Patents Allegedly Infringed, Number, Revised

No definition available.

Name:	skin_GainContingencyPatentsAllegedlyInfringedNumberRevised
Namespace Prefix:	skin_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Gain Contingency, Patents Allegedly Infringed, Partial Denial Of Motion For Summary Judgement Of Non-Infringement, Number

+ References

No definition available.

+ Details

Name:	skin_GainContingencyPatentsAllegedlyInfringedPartialDenialOfMotionForSummaryJudgementOfNonInfringementNumber
Namespace Prefix:	skin_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Litigation Settlement, Amount Awarded, Individual Payment Amount

+ References

No definition available.

+ Details

Name:	skin_LitigationSettlementAmountAwardedIndividualPaymentAmount
Namespace Prefix:	skin_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Litigation Settlement, Amount Awarded, Number of Payments To Be Received

+ References

No definition available.

+ Details

Name:	skin_LitigationSettlementAmountAwardedNumberOfPaymentsToBeReceived
Namespace Prefix:	skin_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Loss Contingency, Number Of Competing Motions

+ References

No definition available.

+ Details

Name:	skin_LossContingencyNumberOfCompetingMotions
Namespace Prefix:	skin_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Number Of Subpoenas Issued by SEC

+ References

No definition available.

+ Details

Name:	skin_NumberOfSubpoenasIssuedBySEC
Namespace Prefix:	skin_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of entity's patents that another entity has allegedly infringed.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483049/450-30-50-1

+ Details

Name:	us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount awarded from other party in judgment or settlement of litigation.

+ References

No definition available.

+ Details

Name:	us-gaap_LitigationSettlementAmountAwardedFromOtherParty
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-4

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-9

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 720
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483359/720-20-50-1

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 460
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 27
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482395/460-10-55-27

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-9

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-4

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 460
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482425/460-10-50-3

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-1

+ Details

Name:	us-gaap_LossContingenciesLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	srt_LitigationCaseAxis=skin_EdgeSystemsLLCVCartessaAestheticsLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=skin_SecuritiesClassActionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=skin_LuvoMedicalTechnologiesIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=skin_AestheticManagementPartnersInc.Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=skin_EMIRAmedUSALLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=skin_SinclairPharmaUSIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=skin_MedicreationsLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=skin_CandelaCorp.Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=skin_MedicalPurchasingResourceLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Commitments and Contingencies (Details)	Apr. 03, 2025 patent	Aug. 26, 2024 patent	Aug. 16, 2024 patent	Jul. 24, 2024 patent	Jul. 08, 2024 patent	Jun. 04, 2024 USD ($) Payment	May 06, 2024 patent	Jan. 16, 2024 competingMotion	Sep. 15, 2022 patent	Dec. 14, 2020 patent	Mar. 31, 2025 subpoena
Loss Contingencies [Line Items]
Number Of Subpoenas Issued by SEC \| subpoena											3
Edge Systems LLC v. Cartessa Aesthetics, LLC
Loss Contingencies [Line Items]
Gain contingency, patents allegedly infringed upon, number										5
Gain contingency, patents allegedly infringed, number, revised										4
Gain contingency, patents allegedly infringed, partial denial of motion for summary judgement of non-infringement, number									3
Securities Class Action
Loss Contingencies [Line Items]
Loss contingency, number of competing motions \| competingMotion								3
Luvo Medical Technologies Inc
Loss Contingencies [Line Items]
Gain contingency, patents allegedly infringed upon, number			5
Aesthetic Management Partners Inc.
Loss Contingencies [Line Items]
Gain contingency, patents allegedly infringed upon, number					5
eMIRAmed USA, LLC
Loss Contingencies [Line Items]
Gain contingency, patents allegedly infringed upon, number		5
Sinclair Pharma US, Inc
Loss Contingencies [Line Items]
Gain contingency, patents allegedly infringed upon, number				5
Medicreations LLC
Loss Contingencies [Line Items]
Gain contingency, patents allegedly infringed upon, number							12
Candela Corp. \| Subsequent Event
Loss Contingencies [Line Items]
Gain contingency, patents allegedly infringed upon, number	5
Medical Purchasing Resource, LLC \| Pending Litigation
Loss Contingencies [Line Items]
Litigation settlement, amount awarded from other party \| $						$ 105,000
Litigation settlement, amount awarded, number of payments to be received \| Payment						4
Litigation settlement, amount awarded, individual payment amount \| $						$ 26,250